Cargando…

Corrigenda: Table Correction. Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis

Detalles Bibliográficos
Autores principales:	Lee, Yong-ho, Cho, Yongin, Lee, Byung-Wan, Park, Cheol-Young, Lee, Dae Ho, Cha, Bong-Soo, Rhee, Eun-Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2019
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834842/ https://www.ncbi.nlm.nih.gov/pubmed/31694085 http://dx.doi.org/10.4093/dmj.2019.0188

Ejemplares similares

Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
por: Lee, Yong-ho, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
por: Kim, Kyung-Soo, et al.
Publicado: (2019)

Corrigenda
Publicado: (2017)

Corrigenda
Publicado: (2017)

Corrigenda
Publicado: (2020)

Corrigenda
Publicado: (2021)

Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Kim, Gyuri, et al.
Publicado: (2015)

Corrigenda: Omission of the Description of Informed Consent
Publicado: (2019)

Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
por: Cho, Yongin, et al.
Publicado: (2022)

Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
por: Lee, Ji-Yeon, et al.
Publicado: (2022)

Corrigenda: The Prevalence of Dementia and Cognitive Impairment in our Acute Medical Admissions
por: Cowley, Sharon, et al.
Publicado: (2018)

Corrigendum: Vegetarian diet, food substitution, and nonalcoholic fatty liver
Publicado: (2018)

Corrigenda: Omission of the Description of Informed Consent on the Identifiable Photos and the Description on Ethical Treatment of Experimental Animals
Publicado: (2017)

Corrigenda: Omission of the Description on the Approval of Institutional Review Board and the Description on Ethical Treatment of Experimental Animals
Publicado: (2018)

Corrigendum to “Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease”
por: Masarone, Mario, et al.
Publicado: (2021)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
por: Lee, Byung-Wan, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective
por: Rhee, Eun-Jung
Publicado: (2019)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
por: Lee, Dae Ho
Publicado: (2020)

Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
por: Han, Eugene, et al.
Publicado: (2020)

Corrigendum to “The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease”
por: Lewis, John E., et al.
Publicado: (2020)

Comparison of clinical utility between diaphragm excursion and thickening change using ultrasonography to predict extubation success
por: Yoo, Jung-Wan, et al.
Publicado: (2019)

Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
por: Lee, Ji-Yeon, et al.
Publicado: (2019)

Corrigendum to “Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice”
por: Lee, Yong-Jik, et al.
Publicado: (2019)

Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
por: Lee, Minyoung, et al.
Publicado: (2020)

Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
por: Kim, Kyung-Soo, et al.
Publicado: (2020)

Based on network pharmacology method to discovered the targets and therapeutic mechanism of Paederia scandens against nonalcoholic fatty liver disease in chicken
por: Wu, Qiang, et al.
Publicado: (2021)

Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial
por: Han, Eugene, et al.
Publicado: (2020)

CORRIGENDUM: Correction of the Figure. Robot-assisted radical prostatectomy has lower biochemical recurrence than laparoscopic radical prostatectomy: Systematic review and meta-analysis
por: Lee, Seon Heui, et al.
Publicado: (2017)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades [Volume 31, Issue 3, September 2012, Pages 163–169]
por: Yun Yang, Byeong, et al.
Publicado: (2013)

The effects of the voglibose on non-alcoholic fatty liver disease in mice model
por: Bae, Jaehyun, et al.
Publicado: (2022)

Survival analysis: Part I — analysis of time-to-event
por: In, Junyong, et al.
Publicado: (2023)

Corrigendum to: Genomic epidemiology reveals the reduction of the introduction and spread of SARS-CoV-2 after implementing control strategies in Republic of Korea, 2020
por: Kwon, Jung-Hoon, et al.
Publicado: (2021)

Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet [Volume 33, Issue 1, March 2014, Pages 33–44]
por: Min, Hye Sook, et al.
Publicado: (2015)

Survival analysis: Part II — applied clinical data analysis
por: In, Junyong, et al.
Publicado: (2023)

Increased Risk of Nonalcoholic Fatty Liver Disease in Individuals with High Weight Variability
por: Jung, Inha, et al.
Publicado: (2021)

Non–Laboratory-Based Self-Assessment Screening Score for Non-Alcoholic Fatty Liver Disease: Development, Validation and Comparison with Other Scores
por: Lee, Yong-ho, et al.
Publicado: (2014)

Effect of duty cycles of tumor-treating fields on glioblastoma cells and normal brain organoids
por: Ye, Eunbi, et al.
Publicado: (2022)

Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
por: Lee, Sejeong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mjbqgns7rc49jtm2ab79ajk4tu